ENDRA Life Sciences Inc. NDRA
Set alert
4.80 USD +0.05 +1.05%
At close · Nov 2
4.79 -0.01 -0.21%
After hours · Nov 2, 4:00 PM ET
4.64 Day range 4.89
3.26 52-week range 6.70
- YTD
- +5.96%
- 1 year
- -8.57%
- Open
- 4.64
- Prev close
- 4.75
- Mkt cap
- 7.20M
- Vol
- 5.78K
- Avg vol
- 31.14K
- EPS
- -6.33
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.64
- High
- 4.89
- Forward P/E
- -0.02
- Beta
- 0.74
- Short ratio
- 0.05
- Inst. own
- 0.49%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 6.68
- 200-d avg
- 291.96
- 1y target
- 2,625.00
YTD chart
Signals (60)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 3 days ago |
| SMA: Bullish | Oct 29, 2026 | 4 days ago |
| SMA: Bearish | Oct 28, 2026 | 5 days ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| MACD: Sell Signal | Sep 28, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 21, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 16, 2026 | 1 month ago |
| RSI: Overbought | Sep 2, 2026 | 2 months ago |
| SMA: Bullish | Aug 26, 2026 | 2 months ago |
| SMA: Bullish | Aug 26, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 17, 2026 | 2 months ago |
| SMA: Bearish | Jul 24, 2026 | 3 months ago |
| SMA: Bearish | Jul 24, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 24, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 22, 2026 | 3 months ago |
| SMA: Bullish | Jul 21, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 20, 2026 | 3 months ago |
Newest 20 of 60.
Analyst view
Consensus: none
Price target (mean) 2,625.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -143.50 | -143.50 – -143.50 | -297.50 | +51.8% | 0 | 0.0% | 1 |
| Next quarter | -142.80 | -142.80 – -142.80 | -455.00 | +68.6% | 0 | 0.0% | 1 |
| Current year | -1,661.10 | -1,661.10 – -1,661.10 | -2,765.00 | +39.9% | 0 | 0.0% | 1 |
| Next year | -538.30 | -538.30 – -538.30 | -1,661.10 | +67.6% | 100.00K | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 7, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| Mar 31, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |